Previous close | 314.21 |
Open | 314.40 |
Bid | 312.11 x 900 |
Ask | 321.95 x 1000 |
Day's range | 312.43 - 321.31 |
52-week range | 298.61 - 541.21 |
Volume | |
Avg. volume | 1,679,344 |
Market cap | 38.678B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 19.76 |
EPS (TTM) | 16.24 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | 3.54 (1.10%) |
Ex-dividend date | 28 Jun 2024 |
1y target est | 362.44 |
LOUISVILLE, Ky., May 02, 2024--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.
Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
Recently, Zacks.com users have been paying close attention to Humana (HUM). This makes it worthwhile to examine what the stock has in store.